Study title: Efficacy and tolerability of Konakion MM Ro 01-6722/135, 1mg vitamin K1 i.v. and 2mg vitamin K1 p.o. in the prophylactic treatment against hemorrhagic disease in premature infants
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Pathological Conditions, Signs and Symptoms [C23] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: PHYTOMENADION | |||||
ATC code: B02BA01 | |||||
Document link: | |||||
Document date: | |||||
Study number: B-162'002 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
Y | - | - | - | - |